Sign in

CIK 0001384101 · Large accelerated filer

VERACYTE, INC.

Sign in to watch
Ticker
VCYT
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205455398
Phone
(650) 243-6300
Business address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Former names
CALDEROME INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,858,989
in 9 filings, $2.9M under 10b5-1 plans

Net −$2,858,989. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Holstein Jens −$932K Director sold 42% of stake
  2. EASTHAM KARIN −$743K Director sold 59% of stake
  3. Febbo Phillip G. −$564K Chief Scientific & Med Officer sold 9% of stake
  4. Bhanji Muna −$162K Director sold 8% of stake
  5. Leite John −$161K Global Chief Commercial Off sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-28 Wygant Jonathan VP, Chief Accounting Officer Shares withheld for taxes −1,306 $50.31 $66K 41,920
2026-10-27 Holstein Jens Director Option exercise 10b5-1 +7,500 $35.30 $265K 34,971
2026-10-27 Holstein Jens Director Sale 10b5-1 −7,500 $50.00 $375K 27,471
2026-10-27 Holstein Jens Director Option exercise · Stock Option (right to buy) 10b5-1 −7,500 20,000
2026-10-27 EASTHAM KARIN Director Option exercise 10b5-1 +10,000 $27.01 $270K 25,097
2026-10-27 EASTHAM KARIN Director Sale 10b5-1 −14,850 $50.00 $743K 10,247
2026-10-27 EASTHAM KARIN Director Option exercise · Stock Option (right to buy) 10b5-1 −10,000 0
2026-10-19 Bhanji Muna Director Sale 10b5-1 −1,864 $43.70 $81K 40,854
2026-09-24 Holstein Jens Director Option exercise 10b5-1 +7,500 $35.30 $265K 34,971
2026-09-24 Holstein Jens Director Sale 10b5-1 −7,500 $47.00 $353K 27,471
2026-09-24 Holstein Jens Director Option exercise · Stock Option (right to buy) 10b5-1 −7,500 27,500
2026-09-21 Leite John Global Chief Commercial Off Sale 10b5-1 −4,015 $40.00 $161K 124,329
2026-09-14 Holstein Jens Director Sale 10b5-1 −5,000 $40.95 $205K 27,471
2026-09-04 McGuire Annie EVP, General Counsel Sale 10b5-1 −2,154 $42.79 $92K 132,260
2026-09-04 McGuire Annie EVP, General Counsel Sale 10b5-1 −1,100 $43.67 $48K 131,160
2026-09-04 Chambers Rebecca Chief Financial Officer Sale 10b5-1 −2,477 $42.81 $106K 167,200
2026-09-04 Chambers Rebecca Chief Financial Officer Sale 10b5-1 −1,175 $43.71 $51K 166,025
2026-09-04 Febbo Phillip G. Chief Scientific & Med Officer Sale 10b5-1 −10,405 $42.89 $446K 135,753
2026-09-04 Febbo Phillip G. Chief Scientific & Med Officer Sale 10b5-1 −2,705 $43.66 $118K 133,048
2026-09-02 Leite John Global Chief Commercial Off Shares withheld for taxes −3,961 $44.88 $178K 128,344

Page 1 of 9 · 168 trades